New York Giants wide receiver Golden Tate lost the appeal of his four-game suspension for violating the NFL policy on performance-enhancing drugs.
Tate's appeal was heard by an arbiter in New York on Tuesday. Tate will reportedly forfeit $465,000 in base salary.
Tate will be eligible to return to the Giants on Sept. 30, one day after the club's Week 4 game against the Washington Redskins.
Tate previously indicated that the positive test came from a prescribed fertility medication.
After the suspension was initially announced on July 27, Tate released a statement.
"This past April, during the offseason, my wife and I decided to see a specialist for fertility planning," the statement began. "I started the treatment prescribed to me and just days later I discovered it contained an ingredient on the league's banned substance list. I immediately discontinued use, I reported the situation to the Independent Administrator of the NFL Policy on Performance-Enhancing Substances, and I spoke with my coaches and general manager. I did all of this well before a failed test was even confirmed."
The Giants signed Tate, 31, to a four-year, $37.5 million contract during the offseason. He spent the 2018 season with the Detroit Lions and Philadelphia Eagles, catching 74 passes for 795 yards and four touchdowns.
Over nine NFL seasons, Tate has 611 receptions for 7,214 yards and 38 touchdowns.
Cody Latimer is expected to join the starting lineup during Tate's suspension. The 26-year-old has 46 catches for 635 yards and four touchdowns in 51 games over five NFL campaigns.